Erythematotelangiectatic, papulopustular, phymatous, ocular subtypes. Topicals, oral therapy, PDL, KTP, and the trigger-avoidance conversation.
Perioral dermatitis causes, zero therapy, topical metronidazole, pimecrolimus, and azelaic acid, oral doxycycline protocols, steroid taper steps, and rosacea…
An evidence-based guide to rhinophyma (rosacea nose). Corrects the drinker's nose myth using JAAD severity data, analyzes occult cancer risks, and compares CO2 laser…
An evidence-first guide to topical azelaic acid. Explains the differences between Azelex 20% and Finacea 15%, clinical timelines, pregnancy safety, and usage protocols.
Rosacea is treated by matching therapy to the feature that bothers you — redness, bumps, visible vessels, thickened skin, or eye symptoms. The evidence ladder for each,…
Compares PDL, KTP, IPL, and Nd:YAG for rosacea by evidence, best use, downtime, cost, and skin-type safety so you can have an informed conversation with your provider.
Vbeam (595 nm PDL) and Excel V (532/1064 nm KTP/Nd:YAG) are the dominant vascular laser platforms. How they compare on mechanism, evidence, comfort, purpura risk, and…
Rosacea in Fitzpatrick IV-VI is often missed because erythema is harder to see. Learn safer diagnosis and treatment choices, including why 1064 nm Nd:YAG is usually…